chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediate: achy, dizzy and weak, low grade fever 48 hours - day 5: achy, dizzy, nausea, diarrhea, congestion, extreme headaches, fever 102 1 week later:  bad Headache, stiff neck, bad congestion, sinus infection, facial pain, achy and fever
Client fainted in the post-vaccine monitoring area at 12:57.  The  left forehead made contact with the floor.  LOC for 5-10 seconds. PHN responded right away and advised client to remain laying on the floor while  EMS was called. Vitals were WNL and client was coherent upon waking. Oriented x3. Fire EMS and hospital EMTs both responded and determined that client was OK. Offered client transport to ER for further evaluation but client declined. Discussed s/sx of concussion and when to  seek treatment over the coming days.  Continued to monitor client in first aid room -provided ice and water. Advised to call emergency contact for a ride home - client declined. Discussed importance of monitoring for concussion. Also discussed s/sx of allergic reaction.  Client reports that he faints frequently, especially when receiving injections and other medical treatments.  Advised client to request to receive 2nd dose laying down . Client remained on site for an hour and remained coherent and oriented.  He called his mom and reports his mom and girlfriend would meet him at home but that he had no concerns and felt "normal".
patient experienced heart attack and subsequently passed away approximately 2 weeks following vaccination. it is not believed to be related to the vaccination.
I recieved the shot at 12 noon Monday and I woke up Tuesday with Hives and swollen eyes. This is Friday and I still have it.This was a flu shot
During a review of internal records, it was found there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
frontal headache for 3 days, left arm pain for 3 days and swelling, general fatigue for 1 week, redness on the tongue, middle anterior part as if it were burned, and the middle distal part a whitish plaque for two days as if I had oral candidosis, Then it started at 300 am I felt something so intense that I woke up, as if the brain were tipping me inside my head and vertigo began, everything turned me when I opened my eyes, as if I had drunk a lot of alcohol and everything gave around me when I opened my eyes, it was lake so strong that I felt that I was falling from my bed,I had to go to my primary doctor because when I changed the position of my head and lowered it, the severe vertigo began and I had to hold on to avoid falling.Then I decided to get the second dose to complete my vaccination despite these adverse effects, the doctor indicated drugs for vertigo and examined me, and now 2 weeks ago that after having a year without menstruation, I was already in menopause, I I have profuse bleeding with clots and I have been bleeding for 15 days.
red rash at the injection site; red rash at the injection site; Inappropriate age; This case was reported by a physician and described the occurrence of injection site rash in a 40-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular) .5 ml. On an unknown date, 3 days after receiving Shingrix, the patient experienced injection site rash, injection site erythema and inappropriate age at vaccine administration. On an unknown date, the outcome of the injection site rash and injection site erythema were recovered/resolved and the outcome of the inappropriate age at vaccine administration was unknown.   It was unknown if the reporter considered the injection site rash and injection site erythema to be related to Shingrix.  Additional details were reported as follows: The case was reported by patient herself. The patient experienced a red rash at the injection site. It developed about 3 days after she received the injection and has resolved. The Shingrix vaccine was recommended for patients 50 years and above however patient received shingrix vaccine at age of 40 years old, which led to inappropriate age at vaccine administration. The reporter did not consent to follow up.
It started to ache on April 3 in arm and shoulder and progressed, and on the 4th I went to ER because I could get comfortable and it raised my blood pressure. ER doctors gave me ibuprofen and Percocet.
Local erythema and inflammation approx 5 x 6 inches surrounding injection site at left thigh. Warm to touch. Dr. prescribed Duricef and follow up on Saturday 9/20/2003.
Extreme High Blood Pressure: 171-112, pain and swelling on the injection site.
The vaccine was administered in May 1999, August 1999 and May 2000. Initial pain in hips started in November 1999 and then progressed to elbows, knees, right hand. Various doctors, Celebrex and now Vioxx, plus pain pills. Hip replacement scheduled for 12/20/2001. A follow up report received 1/28/2002 adds: Left hip replaced on 12/20/2001-righth hip will also be replaced. Cartilege in both hips destroyed in 2 years since taking vaccine. Pain is terrible.
Dizziness and lightheadedness. BP was 104/66, HR 81.  Placed on a litter and placed in Trendelenburg position.  BP 94/59, HR 81, pulse ox 98%.  BP in trendelenburg 126/71  Final bp 125/62, HR 65, pulse ox 99%.  Placed in sitting position. BP was 118/63.  Patient was cool to touch.   Released after 30 minutes with no issues.
A SHARP PAIN  AND NUMBNESS IN INJECTED ARM IMMEDIATELY AFTER THE INJECTION, 25 MINUTES AFTER THE INJECTION I EXPERIENCED A  HEADACHE, CHEST PAIN, DIZZINESS, THROAT SWELLS UP AND IT'S HARD TO SWALLOW, AND BLURRY VISION.I TOOK SOME BENADRYL AND MY THROAT STOPPED CLOSING UP.  I WENT HOME AND LAID DOWN. MY ARM IS STILL NUMB BUT THE PAIN HAS RECEDED. MY ARM ALWAYS SWELLS UP WHENEVER I RECEIVE AN INJECTION. 2 HOURS LATER THROAT IS STILL A LITTLE SWOLLEN, AND I HAVE A SLIGHT HEADACHE. CHEST STOPPED HURTING. LEFT ARM IS STILL NUMB.
Suspected vaccination failure; I know someone got the vaccine shot and got the shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age group was not reported but was captured as an adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
2/9/11 4:30pm facial swelling & fine, red, raised rash over rest of body. Seen in ER & given BENADRYL. Body rash gone before leaving ER and facial swelling gone by AM of 2/10/11.
COMPLAINS OF HEADACHE, FATIGUE AND FEELS LIKE MUSCLES ARE CRAMPING.
metallic taste began within the hour and has lasted for weeks with no relief ringing in both ears and began hours later after injection and comes and goes, have not had this until the injection pain along entire left arm where it was painful to lift arm and perform much movement
Patient stated that he "got dizzy and face was flushed the her blacked out". The nursing staff here at the clinic took his vitals, gave him a bottle of water. No injury noted. Patient denied pain or injury.
SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION.  LEFT SHOULDER PAIN POST COVID VACCINE ADMINISTRATION.  EXAM IS NORMAL BUT APPEARS INJECTION WAS PLACED INTHE INSERTION OF THE DELTOID OR POSSIBLY SUBACROMIAL SPACE VICE THE DELTOID MUSCLE BELLY BASED ON PHYSICAL EXAM AND SUBJECTIVE COMPLAINT.
pt recv flu & pneumococcal vax combined & given in one inj & exp redness, sl swelling, site warm;
Patient received HPV vaccine, seconds later became unresponsive for 1-2 seconds, became diaphoretic, cold-clammy skin, and had low pressure 70/25 Pulse 108. Patient was given 2 bottles of water a total of 472 mL blood pressure repeated and obtained 112/39 P 57. After the two bottles of water, patient was more alert, no longer diaphoretic, and denied dizziness, lightheadedness, N/V, and visual changes.
30 min, c/o L hand (btw 2nd and 3rd finger) swelling, no pain, no itching.
HPV vaccine used for hands warts; Literature Report:.  This literature marketed report has been received from the authors of the published article, titled as stated above concerning a 50 year old male patient. The patient's pertinent medical history included therapy with liquid nitrogen, curettage and topical fluoracil (reported as 5-FU). The patient's current conditions and concomitant medications were not reported.   On an unspecified date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (manufacturer unknown) for hands warts (product use in unapproved indication) (strength, dose, frequency, route of administration, lot number and expiration date were not reported).   The patient's immune status was reported as none. The patient was followed up for treatment for 2 months.  The authors informed that on an unspecified date, the patient died due to natural causes.   A copy of the published article is attached as further documentation of the patient's experience.  This is one of several reports received from the same literature.  Follow-up information was received via telephone call on 02-APR-2020.  A request was made for patient identifiers, events experienced and causal relationships.; Sender's Comments:  US-009507513-1912USA001729:
MILD BODY ACHES- BACK; LOW GRADE FEVER; HEADACHE; FATIGUE; TROUBLE SLEEPING; FEELING VERY UNCOMFORTABLE; This spontaneous report received from a vaccine facility concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included sulfa allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-MAR-2021, Laboratory data included: Physical examination (NR: not provided) Cleared. On 11-MAR-2021, the subject experienced trouble sleeping. On 11-MAR-2021, the subject experienced feeling very uncomfortable. Laboratory data included: Low grade fever (NR: not provided) 99.2-99.9 F. On 11-MAR-2021 08:00, the subject experienced mild body aches- back. On 11-MAR-2021 08:00, the subject experienced low grade fever. On 11-MAR-2021 08:00, the subject experienced headache. On 11-MAR-2021 08:00, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from low grade fever, mild body aches- back, headache, fatigue, trouble sleeping, and feeling very uncomfortable. This report was non-serious.
Shoulder swollen and red - warm to touch c/o headache and flu like symptoms began 7 PM on 6/12/2007. Tdap given AM 6/12/2007. Checked by MD 6/15/07 - will treat with antibiotic.
large red mark on my breast; skin discoloration on left breast; underarm pain; This case was reported by a consumer via Shingrix GSK call center representative and described the occurrence of axillary pain in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th December 2021, the patient received the 1st dose of Shingrix. In December 2021, less than a week after receiving Shingrix, the patient experienced axillary pain, localized erythema and skin discoloration. On an unknown date, the outcome of the axillary pain was recovered/resolved and the outcome of the localized erythema and skin discoloration were unknown.   It was unknown if the reporter considered the axillary pain, localized erythema and skin discoloration to be related to Shingrix.  Additional details were reported as follows: The patient received first dose of Shingrix and experienced underarm pain for two days. At the end of second day, the patient had a large red mark on the left side of breast, about the size of palm of hand. The patient said it was large red skin discoloration of left breast. Consent to follow up had been requested.
Received Td in right deltoid - arm swollen, red area - 2"x3" Received PPV23 - left arm - swollen, warm and red
about 6PM fussy then went to sleep; woke @ 9PM both legs swollen & red, took bottle & back to sleep; then 1AM awake & fussy & fever; mom concerned about swollen legs & screaming; took pt to ER;
About 12 hours after receiving the 2nd shot of the Pfizer vaccine, I had severe body aches, chills, sweats. I didn?t sleep most of the night. My body temperature reached 99.6 F which is high for me because I tend to be cold. The symptoms continued through the next day 10/30. I would get up out of bed to use the restroom or make myself something to eat, and I felt very dizzy and weak legged. I was bed ridden the entire day on 10/30. 10/31, I had started to feel better, but also had chest pain that started. After a couple hours, it would go away and come back for a couple hours and then go away. By 11/1, I woke up at 4:00am with severe chest pain. This time it wouldn?t go away like normal. I called my doctor and got in to see her for an appointment at 10:00am. Still the chest pain was there. My temperature was 99.1F by then. I was so fatigued. It was worse than having actual COVID-19 which I had in December 2020. I had an EKG done which came back normal. My doctor wrote me out from work for the week, and I worked from home as I could. I was so exhausted and tired all the time.  By Thursday, 11/5, the chest pain had gone away along with the other symptoms except for fatigue. On Friday, 11/6 left the house to go grocery shopping. After 1 hour, I was exhausted. I came home around 12:00pm and had a migraine headache set in. One of the worst I?ve had in my life. The migraine had lasted the rest of that day and all through 11/7. Around 1:00pm on Friday 11/5 I started my menstrual cycle which was 3 days early for me. It was light and spotty. That?s not normal for me to be early or for it to be just spotty. Around 4:00am I woke up to a extreme menstrual bleeding. I hopped out of bed and blood had soaked through my entire super heavy overnight pad and was running down both sides of my legs. I?ve never had such severe bleeding in my life. My migraine headache had moved to the right side temple of my head and was pounding. Around 9:00am 11/6 I had nausea and the chills all over again like the day right after I had received the 2nd dose. Around 6:00pm, my migraine had subsided. My body aches and chills are gone. I still have extreme bleeding from my cycle, but I?ll see what happens in the days ahead. The fatigue and brain fog is still lingering.
migraines, left hip pain (progressively worsening), constant diarrhea, fatigue despite sleeping 14 hours, sweating during sleep, neck pain, SOB, painful and difficult to start urinating
Dtap injection was given in the left deltoid. One day after the injection a 4 cm x 3 cm indurated oval shape macular lesion appeared in the upper left arm where injection was given and is associated with mild tenderness. No fever or other issues. Recommendation: Benadryl and Tylenol PRN and instructions to watch the progression/improvement of the lesion site.
Rash Vesicular Information has been received from a health professional concerning a female patient with no medical history and no allergies who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. It was reported that approximately six weeks after receiving varicella virus vaccine live (Oka/Merck) the patient developed what appeared to be a varicella type rash that was described as 10 small vesicular lesions on her legs, chest and arms. There were no other complaints. The patient was seen on 05-OCT-2005. No treatment was ordered. There were no laboratory or diagnostic tests performed. It was noted that lesions were starting to dry up and that the patient was recovering. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Spoke with mother and stated patient's arm around her flu shot received yesterday is larger, red and hot. No fever but have been giving TYL, Ibuprofen. No drainage. Blood sugars within usual limits, 80's pre dinner tonight.
One day after immunization seen for erythema + warmth at right arm DTaP immunization site. Did not respond to Keflex (started day 2). Responded well to Augmentin and Allegra. Reported due to similar incident 3 w later same office same nurse different shot.
Severe left arm pain at/around vaccine site.  Slowly improving over the last few weeks.
Rashes that looked like mosquito bites; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Jun-2021 and was forwarded to Moderna on 24-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rashes that looked like mosquito bites) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided. .     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rashes that looked like mosquito bites). At the time of the report, RASH (Rashes that looked like mosquito bites) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.   This case was linked to MOD-2021-247899, MOD-2021-247929 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Additional information received contains no new information. On 16-Aug-2021: Follow-up received on 16-AUG-2021 ,containing no new information
Around 4/20/2021 developed itching along left jawline.  Progressed to rash and bumps along left jawline/chin and rash and bumps above left temple near left eye (this area was sensitive).  Itching continued and worsened.  4/23/2021 had telehealth visit - suspected shingles and was started on Valtrex 1,000mg three times daily.  By 4/25/2021, rash had mostly resolved along left jaw/chin and above temple near left eye ..still some slight itching (but improved). By 4/26/2021, rash, bumps and itching nearly completely resolved.
This spontaneous prospective pregnancy report was received from a nurse regarding a 32 year old female patient. Her medical history, concurrent condition and concomitant medication was unknown. The patient's last menstrual period (LMP) was 22-MAY-2017. On 26-MAY-2017, the patient was vaccinated with M-M-R II (lot # L041455, expiration date 22-OCT-2017, subcutaneously) for prevention of measles/mumps/rubella with sterile diluent (subcutaneously, lot number, expiration date and indication unknown) (doses unknown). On 11-JUN-2017, the patient inadvertently became pregnant due to condom breakage during intercourse on the same day (maternal exposure before pregnancy). On an unknown date, the patient visited physician. The estimated date of delivery (EDD) was 26-FEB-2018. The pregnancy outcome was outcome pending. Additional information has been requested.
Death.  While driving patient passed out and was found by County Sheriffs Office.  EMT was called  and could not save patient.  M.E. Declared patient dead at 7:20 PM on May 4, 2021
The patient mistakenly received a third dose of Shingrix over a year later since the second dose. The patient reported typical post-vaccination symptoms associated with this vaccine (i.e. fatigue, aches, mild fever). Patient requested and was provided with available safety data from the manufacturer (GSK) regarding patients receiving a third dose.
Swelling at the injection site, in the arm; Redness at the injection site, in the arm; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 83-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th August 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 31st August 2022, 1 days after receiving Shingrix, the patient experienced injection site swelling and injection site erythema. On an unknown date, the outcome of the injection site swelling and injection site erythema were not recovered/not resolved.   It was unknown if the reporter considered the injection site swelling and injection site erythema to be related to Shingrix.     Additional Information: GSK Receipt Date: 07-SEP-2022 Reporter's comment: The patient self-reported this case. The patient received dose of Shingrix vaccine in the left arm and next day after the vaccination she had swelling and redness at the injection site. The patient also reported that the redness and swelling lasted for about 4 days and then started to went away. The patient reported that today(on the day of reporting), the redness and swelling had returned in the arm where she got her Shingrix vaccine. No HCP(Health Care Professional) for follow up. The reporter did not consent to follow-up.
Giving 0.25 ml instead of 0.2 ml; No Adverse Event; This spontaneous case was reported by an other health care professional and describes the occurrence of INCORRECT DOSE ADMINISTERED (Giving 0.25 ml instead of 0.2 ml) and NO ADVERSE EVENT (No Adverse Event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215L22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Giving 0.25 ml instead of 0.2 ml) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, INCORRECT DOSE ADMINISTERED (Giving 0.25 ml instead of 0.2 ml) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (Giving 0.25 ml instead of 0.2 ml).    Concomitant and treatment medications were not reported.  It was reported that the nurse was at a pediatric practice. They gave monovalent and bivalent Moderna vaccine. They gave the wrong dose of the bivalent (6 months to 5 years) with lot number 215K22A. They gave 0.25 ml instead of 0.2 ml from14-Dec-2022 to 11-Jan-2023. She wants to know any recommendations to give the patients or what concerns to warn the parents. No parents had been contacted yet, no reports of adverse reactions received by the nurse. The nurse thinks there may be less than 10 patients involved. She may be able to email the information if necessary, but she does not had everything on hand at the moment. She will also had to check with the practice owner for release of that information.